Phio Pharmaceuticals Corp expected to post a loss of $1.30 a share - Earnings Preview

Phio Pharmaceuticals

18/03/2024 11:03

* Phio Pharmaceuticals Corp  PHIO.OQ   PHIO.O  is expected
to report results on March 20 (estimated) for the period ending
December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Phio Pharmaceuticals
Corp is
for a loss of $1.30 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Phio
Pharmaceuticals Corp is $4.00​, above​ its last closing price
of $0.95. ​​​

This summary was machine generated March 18 at 11:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)